SaltMED
SaltMED designs, manufactures, and sells The SaltFacial, a Class II FDA-cleared medical device combining sea salt resurfacing, ultrasound, and LED phototherapy, sold B2B to dermatologists, plastic surgeons, and med spas in the US with worldwide reach.
- Company typePrivate
- Founded2005
- HeadquartersCardiff By The Sea, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What SaltMED does
SaltMED (legal entity Med-Aesthetics Solutions, Inc., incorporated 2005, rebranded SaltMED in March 2021) designs, manufactures, and sells The SaltFacial, a Class II FDA-cleared medical aesthetic device that combines three modalities on a single platform: positive-pressure sea salt resurfacing, cavitation aesthetic ultrasound, and medical-grade LED phototherapy (blue, red, near-infrared). The device is sold B2B to dermatologists, plastic surgeons, cosmetic surgeons, med spas, and physician assistants primarily in the United States, with a stated worldwide reach. SaltMED monetizes through one-time device sales, recurring consumable purchases (Salt Kit, Gliding Gel), and practitioner training services. Go-to-market combines enterprise field sales, inside sales via online specialty-specific intake forms, and event-driven demand generation including webinars and industry exhibitions. A provider locator on the company's website drives patient referrals to certified practitioners.
The company's product is differentiated by a patented sea salt delivery handpiece and clinical evidence published in the Journal of Clinical and Cosmetic Dermatology, including outcomes such as a 72.5% reduction in acne-induced inflammation versus 36.8% with antibiotics alone and 5.6-day faster post-surgical recovery. Named customers are board-certified practitioners operating individual practices, with reported utilization as high as 8 hours per day, 6 days per week, and rebooking rates near 70%. Distribution includes a core channel partnership with Merz Aesthetics.
In December 2025, SaltMED was acquired by Micro Imaging Technology, Inc. (MIT/MMTC), a California-based public company, which subsequently announced the acquisition of Cellmyx in June 2026 to create a combined aesthetics and regenerative medicine manufacturing and distribution platform with stated national and worldwide ambitions. SaltMED operates from its headquarters and manufacturing facility, both in Irvine, California.
SaltMED firmographics
Firmographics- Name
- SaltMED
- Legal name
- Med-Aesthetics Solutions, Inc.
- Website
- https://saltmed.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- SaltMED designs, manufactures, and sells The SaltFacial, a Class II FDA-cleared medical device combining sea salt resurfacing, ultrasound, and LED phototherapy, sold B2B to dermatologists, plastic surgeons, and med spas in the US with worldwide reach.
- Ownership category
- akta.pro rank
SaltMED industry classification
Industry- Product category
- Medical Aesthetic Equipment
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Salt Therapy (Halotherapy) (HSADAKAJ)
Keywords
Where SaltMED is headquartered
LocationHeadquarters
- HQ city
- Cardiff By The Sea
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
SaltMED business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales
Revenue model
- Medical Device Sales: Sale of The SaltFacial multi-modality platform device to physicians, healthcare providers, med spas, dermatologists, and plastic surgeons. The device is a Class 2 medical device available for purchase and use in medically supervised facilities.
- Consumable Products: Recurring sales of consumable supplies including Salt Kit and Gliding Gel required for The SaltFacial treatments. Healthcare providers order supplies through the website order form.
- Professional Services and Training: Training and support services for practitioners. A dedicated Training & Support Resources Center provides ongoing education for certified SaltFacial providers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | The SaltFacial Device - Quote-based pricing for medical equipment |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels6 records
SaltMED product offering
Product offeringCore offering
SaltMED manufactures and sells The SaltFacial, an FDA-cleared Class II medical device that combines three modalities—sea salt resurfacing, aesthetic ultrasound, and LED phototherapy—into one platform for non-invasive skin renewal therapy. The company sells the device directly to physicians, dermatologists, plastic surgeons, and medical spas, and generates recurring revenue through consumable supplies (Salt Kit and Gliding Gel) required to perform treatments.
Product overview
SaltMED offers The SaltFacial®, a multi-modality platform system combining three distinct technologies: Sea Salt Resurfacing, Aesthetic Ultrasound, and LED Phototherapy. The core product is The SaltFacial Class II medical device that delivers a three-step skin renewal therapy. The system can be used as an integrated 3-step treatment or each modality used independently. Consumable supplies include Salt Kits and Gliding Gel.
Differentiator
Problem solved
Functional benefit
Brands
- The SaltFacial: A Class II medical facial device that combines three technologies: sea salt resurfacing, aesthetic ultrasound, and LED phototherapy for skin renewal therapy.
Products and services
- The SaltFacial
Quantifiable outcome
- 100% patient satisfaction rate with 80% reporting being extremely satisfied
- +4 more outcomes
Companies that use SaltMED
Customer profileNamed customers10 records
Segments3 records
Ideal customer profiles1 record
SaltMED technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
SaltMED partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Micro Imaging Technology (MIT)coreMIT acquired SaltMED/SaltFacial in December 2025, making SaltMED part of a larger public company (MMTC) focused on medical imaging and aesthetics. This acquisition complements MIT's broader portfolio including Cellmyx acquisition, strengthening manufacturing and distribution capabilities nationally and worldwide.
- Merz AestheticscoreMerz Aesthetics partnership validates The SaltFacial as a premium, scientifically-backed technology in the medical aesthetics market. Dr. Werschler specifically cited the Merz partnership as invoking trust from patients and practitioners. The partnership positions SaltMED within Merz's established distribution network for aesthetic devices.
- JaanuuminorJaanuu is listed as a partner on SaltMED's website footer. Jaanuu is a healthcare apparel brand, suggesting a cross-promotional or co-marketing relationship within the healthcare/aesthetics industry.
Scale indicators8 records
Recent moves5 records
Expansion highlights5 records
SaltMED competitors and assessment
Company assessmentBroad incumbents
- Cynosure: Cynosure produces aesthetic and medical laser/light platforms (Potenza, TempSure, Mona Lisa Touch) targeting dermatology and plastic surgery practices that overlap with SaltMED's customer base.
- InMode: InMode develops minimally invasive and non-invasive aesthetic platforms (Morpheus8, Evoke, EmpowerRF) sold to the same physician and med-spa channel as SaltMED.
- Lumenis: Lumenis manufactures light-based and energy-based aesthetic and surgical devices (M22, Stellar, SPLENDOR X) sold into the same physician customer accounts as The SaltFacial.
- Cutera: Cutera manufactures aesthetic laser and light-based devices (e.g., AviClear, excel V, truSculpt) sold to the same physician and med-spa accounts, competing for the device capital budget that SaltMED depends on.
- Sciton: Sciton makes multi-modality aesthetic laser and light platforms (BBL, Halo, mJOULE) sold to medical practices and med-spas, directly overlapping SaltMED's pre/post-procedure positioning.
- BTL Industries: BTL makes non-invasive aesthetic devices (EMFACE, Emsculpt, Exilis) for facial and body rejuvenation, often sold to the same dermatology, plastic surgery, and med-spa buyers as SaltMED.
- Alma Lasers: Alma Lasers produces a broad portfolio of aesthetic laser, light, RF, and ultrasound platforms (Accent, Harmony XL, Soprano) sold into the same med-spa and physician channel as The SaltFacial.
- Solta Medical: Solta (Thermage, Fraxel, Clear+Brilliant) is a broader aesthetic device incumbent that sells energy-based skin rejuvenation platforms into the same dermatologist and plastic surgeon channels SaltMED targets, with multi-modality positioning similar to The SaltFacial.
Direct peers
- Edge Systems (HydraFacial): Edge Systems manufactures the HydraFacial device, the most direct category competitor to The SaltFacial: a multi-step skin treatment platform sold to med-spas, dermatologists, and plastic surgeons with both device and recurring serum/consumable revenue.
Others
- Merz Aesthetics: Strategic channel partner rather than a direct device competitor; Merz Aesthetics distributes injectables and Ultherapy, and partners with SaltMED to bundle Ultherapy with The SaltFacial, reaching the same aesthetic practices through its sales network.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
SaltMED social profiles
Digital presenceSaltMED compliance and trust
Trust signalCompliance1 record
SaltMED financial estimates
Financial estimateRevenue estimate
Valuation estimate
SaltMED leadership team
Management profileNumber of profiles
SaltMED funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SaltMED M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SaltMED
What does SaltMED do?
SaltMED manufactures and sells The SaltFacial, an FDA-cleared Class II medical device that combines three modalities—sea salt resurfacing, aesthetic ultrasound, and LED phototherapy—into one platform for non-invasive skin renewal therapy. The company sells the device directly to physicians, dermatologists, plastic surgeons, and medical spas, and generates recurring revenue through consumable supplies (Salt Kit and Gliding Gel) required to perform treatments.
Is SaltMED a public or private company?
SaltMED is a private company. It is classified as corporate owned and is currently acquired.
When was SaltMED founded?
SaltMED was founded in 2005. It employs 11 to 50 people.
Where is SaltMED based?
SaltMED is headquartered in Cardiff By The Sea, United States, in the North America region.
How does SaltMED make money?
Three revenue lines are on record. Medical Device Sales are the primary driver. The others are consumable Products and professional Services and Training.
Who are SaltMED's main competitors?
Broad incumbents on record are Cynosure, InMode, Lumenis, Cutera, Sciton, BTL Industries, Alma Lasers and Solta Medical. Edge Systems (HydraFacial) is listed as a direct peer. Merz Aesthetics is listed as an others.
Does SaltMED have an API?
No public API is recorded for SaltMED.
What industry is SaltMED in?
SaltMED's product category is Medical Aesthetic Equipment. Its primary akta.pro industry code is HSADAKAJ, Salt Therapy (Halotherapy). Its NAICS code is 339112 and its SIC code is 3841.